Total Payments
$41,841
2024 Payments
$16,373
Companies
9
Transactions
161
Payment Breakdown by Category
Other$22,705 (54.3%)
Travel$8,257 (19.7%)
Consulting$5,778 (13.8%)
Food & Beverage$5,101 (12.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,705 | 22 | 54.3% |
| Travel and Lodging | $8,257 | 24 | 19.7% |
| Consulting Fee | $5,778 | 9 | 13.8% |
| Food and Beverage | $5,101 | 106 | 12.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $33,249 | 121 | $0 (2024) |
| Madrigal Pharmaceuticals | $7,627 | 19 | $0 (2024) |
| ABBVIE INC. | $291.17 | 10 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $242.69 | 5 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $226.66 | 2 | $0 (2024) |
| ALCRESTA THERAPEUTICS, INC. | $124.99 | 1 | $0 (2022) |
| ORPHALAN INC | $32.64 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $29.74 | 1 | $0 (2023) |
| Mirum Pharmaceuticals, Inc. | $17.17 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,373 | 62 | Gilead Sciences, Inc. ($8,345) |
| 2023 | $6,534 | 33 | Gilead Sciences, Inc. ($6,302) |
| 2022 | $12,040 | 38 | Gilead Sciences, Inc. ($11,732) |
| 2021 | $6,894 | 28 | Gilead Sciences, Inc. ($6,870) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.53 | General |
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,215.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $133.56 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 10/24/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $117.69 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $56.95 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $25.56 | General |
| Category: LIVER DISEASE | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $38.17 | General |
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 10/07/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Rare Disease | ||||||
| 10/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.12 | General |
| 10/07/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: Rare Disease | ||||||
| 10/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.53 | General |
| 10/03/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $980.00 | General |
| Category: HCV | ||||||
| 09/28/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $552.57 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $254.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $186.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $94.62 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $77.39 | General |
| Category: LIVER DISEASE | ||||||
About Alyson Harty, NP
Alyson Harty, NP is a Adult Health healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2020. The National Provider Identifier (NPI) number assigned to this provider is 1285253518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alyson Harty, NP has received a total of $41,841 in payments from pharmaceutical and medical device companies, with $16,373 received in 2024. These payments were reported across 161 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,705).
Ad
Practice Information
- Specialty Adult Health
- Other Specialties Adult Health
- Location New York, NY
- Active Since 04/16/2020
- Last Updated 02/26/2024
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1285253518
Products in Payments
- Epclusa (Drug) $25,994
- REZDIFFRA (Drug) $7,600
- MAVYRET (Drug) $291.17
- IQIRVO (Drug) $242.69
- OCALIVA (Drug) $226.66
- RELIZORB (Device) $124.99
- Livdelzi (Drug) $120.56
- CUVRIOR (Drug) $32.64
- TERLIVAZ (Drug) $29.74
- RESMETIROM (Drug) $27.71
- Livmarli (Drug) $17.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in New York
Ms. Donna Catamero, Np, NP
Adult Health — Payments: $173,379
Adult Health $173,379
Mrs. Juliet Escalon, Anp, ANP
Adult Health — Payments: $45,931
Adult Health $45,931
Teshmanie Rampersaud, Np, NP
Adult Health — Payments: $22,782
Adult Health $22,782
Mrs. Monica Richey, Np, NP
Adult Health — Payments: $17,240
Adult Health $17,240
Damaris Carriero, Np, NP
Adult Health — Payments: $15,518
Adult Health $15,518
Christina Russomanno, N.p, N.P
Adult Health — Payments: $14,596
Adult Health $14,596